Ọgwụgwọ mgbanwe nwere ike bụrụ ọgwụgwọ kachasị dị irè maka ọrịa leukemia nlọghachite

Otu n'ime ndị na-eduga oncologists n'ụwa kwenyere na ọhụrụ immunotherapies maka ihe a na-akpọ "ọgwụ ndụ ndụ" nwere ike ịbụ "ngwa agha kachasị dị irè n'ọgụ a na-alụso ọrịa leukemia ọgụ", na-enye mmụba dị ịrịba ama na ọnụego ndụ.

Dr. Rabih Hanna, onye na-ahụ maka ahụike ụmụaka, ọkachamara n'ọrịa oncologist na onye na-atụgharị ọkpụkpụ ọkpụkpụ na Cleveland Clinic na United States, bụ onye na-eleta ihe ngosi ahụike na ogbako Arab Health nke a na-eme ugbu a na Dubai, kwuru na ọgwụgwọ na chimeric receptors maka cell T, mara. dị ka "karti" Tgbọ ala TỌ na-adabere n'iwepụta mkpụrụ ndụ T n'ahụ onye ọrịa ma gbanwee mkpụrụ ndụ ihe nketa na ụlọ nyocha iji wakpo mkpụrụ ndụ kansa.

A na-adọta ọbara onye ọrịa ma mee mgbanwe ụlọ nyocha na mkpụrụ ndụ T, nke bụ ụdị sel usoro ahụ ji alụso ọrịa ọgụ, iji nwee ike ịwakpo ma gbuo mkpụrụ ndụ kansa. A na-ewebata mkpụrụ ndụ Karti a gbanwere n'ime ahụ onye ọrịa site na ọbara, n'ime oge ọgwụgwọ ụbọchị iri na anọ.

Cleveland Clinic Children's bụ otu n'ime ụlọ ọgwụ izizi nyere ụmụaka nwere ọrịa kansa ọgwụgwọ chimeric T-cell, ọgwụgwọ akwadoro na nso nso a maka ojiji na United States na Europe.

Dr. Hanna kwusiri ike na nsonaazụ mmalite nke iji chimeric receptor T-cell (Karti) ọgwụgwọ na ọgwụgwọ ụmụaka na ndị na-eto eto nwere pre-B-cell nnukwu lymphoblastic leukemia. BOtu ụdị lymphoma DLBCL (Kwụsa nnukwu lymphoma B-cell) "bụ ihe na-ekwe nkwa ma na-adọrọ mmasị," na-akọwa ọgwụgwọ a dị ka "ọgwụ kachasị mma nke e mere iji lụso ọrịa leukemia ọgụ ruo mgbe ebighị ebi" n'ihi na ọ na-anọgide n'ọbara dị ka ọgwụ dị ndụ, ma gbakwụnye, sị: "T-cell therapy na-enye. ike dị egwu na ọgwụgwọ ọrịa leukemia, ọ bụghị Karịsịa n'etiti ndị ọrịa na-erubeghị afọ 26 nwere nnukwu ọrịa leukemia lymphoblastic na-alaghachi azụ.

N'okwu ya na Arab Health Conference, Dr. Hanna ga-ekwu maka ihe ịma aka na ohere dị n'ịgwọ ọrịa cancer na ụmụaka, ndị nọ n'afọ iri na ụma na ndị na-eto eto. O kwenyere na ọgwụgwọ T-cell nwere ike ịdị irè ọbụna na ndị okenye nwere nnukwu lymphoma B-cell na-abụghị Hodgkin.

Dr. Hanna mechiri site n’ikwu, sị: “Ugbu a anyị na-ahụ mmụba dị ukwuu n’ọnụ ọgụgụ nlanarị, na-eru pasent 70 ma ọ bụ 80 n’ozuzu ya.”

Dị ka Dr. Hanna si kwuo, a na-emepụta ọgwụgwọ T-cell ugbu a iji gwọọ ọrịa cancer ọbara ndị ọzọ, dị ka ọrịa leukemia lymphocytic na-adịghị ala ala na ụdị lymphoma ndị ọzọ na multiple myeloma.

A ga-enwe 28th Arab Health Conference site na 31-XNUMX Jenụwarị na Dubai World Trade Center na Conrad Dubai Hotel.